Sophia Zoungas
#155,951
Most Influential Person Now
Australian endocrinologist
Sophia Zoungas's AcademicInfluence.com Rankings
Sophia Zoungasphilosophy Degrees
Philosophy
#10346
World Rank
#14175
Historical Rank
Logic
#7244
World Rank
#8942
Historical Rank
Download Badge
Philosophy
Why Is Sophia Zoungas Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sophia Zoungas is a clinical endocrinologist from Victoria, Australia. She is recognised for her work in the management of diabetes and its vascular complications and leads Australia's largest translational research program in diabetes care and benchmarking of diabetes services. Zoungas's research explores the link between diabetes, glucose levels and cardiovascular risks and has enabled people with diabetes to be prescribed medication that reduce their cardiovascular risk factors. She is head of the School of Public Health and Preventative Medicine at Monash University and is the Professor of Diabetes, Vascular Health and Ageing and is also deputy director of Research at Alfred Health.
Sophia Zoungas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. (2014) (1401)
- Severe hypoglycemia and risks of vascular events and death. (2010) (1317)
- Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
- Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
- KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. (2020) (499)
- Diabetes and Hypertension: A Position Statement by the American Diabetes Association (2017) (465)
- Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials (2009) (380)
- Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes (2014) (322)
- Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. (2017) (315)
- Diabetic kidney disease (2015) (303)
- Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds (2012) (297)
- Diabetic kidney disease (2015) (291)
- Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial (2014) (266)
- Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
- Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. (2006) (235)
- Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes (2016) (200)
- Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. (2019) (187)
- Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2009) (187)
- Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
- Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy (2009) (177)
- Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
- Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. (2010) (166)
- Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. (2015) (166)
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus (2016) (161)
- Minimizing Hypoglycemia in Diabetes (2015) (154)
- The management of insulin resistance in polycystic ovary syndrome (2007) (138)
- Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE (2011) (131)
- The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2020) (129)
- The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. (2013) (129)
- Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment. (2020) (128)
- Contemporary model for cardiovascular risk prediction in people with type 2 diabetes (2011) (123)
- ARTERIAL STIFFNESS AND CARDIOVASCULAR OUTCOME (2007) (121)
- Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS (2006) (119)
- Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. (2007) (117)
- Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease (2012) (112)
- Arterial function after successful renal transplantation. (2004) (112)
- Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. (2014) (110)
- The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis (2012) (109)
- Oral Disease in Relation to Future Risk of Dementia and Cognitive Decline: Prospective Cohort Study Based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (Advance) Trial (2013) (109)
- Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
- Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus (2012) (97)
- Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy (2012) (93)
- Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. (2010) (89)
- Recent Patterns of Multimorbidity Among Older Adults in High-Income Countries. (2019) (88)
- Obesity and the Microvasculature: A Systematic Review and Meta-Analysis (2013) (85)
- Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention. (2018) (82)
- Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. (2010) (79)
- Do sulphonylureas still have a place in clinical practice? (2018) (78)
- Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes (2016) (78)
- Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE (2009) (77)
- Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National Diabetes Audit (ANDA) 2016 (2018) (77)
- Preoperative Estimates of Glomerular Filtration Rate as Predictors of Outcome after Surgery: A Systematic Review and Meta-analysis (2013) (76)
- The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes (2014) (75)
- Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses (2020) (75)
- Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity. (2015) (74)
- Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study (2016) (73)
- Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline (2020) (72)
- Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes (2017) (69)
- Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial (2013) (68)
- The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes (2013) (66)
- The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus (2013) (65)
- Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. (2015) (65)
- Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health. (2014) (64)
- Antioxidants for chronic kidney disease. (2012) (64)
- Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies (2016) (63)
- Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis (2022) (61)
- Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes (2015) (61)
- Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. (2010) (60)
- A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society (2014) (59)
- A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. (2009) (59)
- Assessment of Cardiovascular Disease Risk in South Asian Populations (2013) (58)
- Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus (2012) (58)
- Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial (2014) (55)
- The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study (2016) (55)
- A placebo‐controlled trial of long‐term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function (2001) (55)
- Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). (2012) (54)
- Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis (2018) (54)
- A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years (2018) (51)
- KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. (2022) (51)
- Preventing Weight Gain in Women in Rural Communities: A Cluster Randomised Controlled Trial (2016) (50)
- The association between patient activation and self‐care practices: A cross‐sectional study of an Australian population with comorbid diabetes and chronic kidney disease (2017) (49)
- Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. (2017) (47)
- Carotid Artery Intima–Medial Thickness Is Increased In Chronic Renal Failure (2000) (46)
- A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks (2018) (46)
- Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial (2012) (46)
- Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial (2010) (43)
- Intensive glucose control and risk of cancer in patients with type 2 diabetes (2011) (43)
- Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON (2017) (41)
- Statins for Primary Prevention in Older Adults—Moving Toward Evidence‐Based Decision‐Making (2018) (41)
- Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke (2018) (40)
- Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis (2018) (40)
- The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial. (2010) (39)
- Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (37)
- Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. (2017) (36)
- Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial (2017) (36)
- Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control (2016) (36)
- Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes (2016) (35)
- The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial (2016) (35)
- Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies (2018) (35)
- Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease (2016) (34)
- Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes (2017) (34)
- The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis. (2020) (34)
- Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study (2017) (33)
- Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World? (2011) (33)
- Patterns of statin use and long‐term adherence and persistence among older adults with diabetes (2018) (32)
- Risk perception in women: a focus on menopause (2008) (31)
- Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes (2016) (31)
- The risk of cancer in people with diabetes and chronic kidney disease. (2012) (30)
- Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies (2010) (29)
- Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. (2012) (29)
- Comparison of Near-Patient Capillary Glucose Measurement and a Risk Assessment Questionnaire in Screening for Type 2 Diabetes in a High-Risk Population in Rural India (2011) (29)
- Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes (2020) (28)
- The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach (2015) (28)
- Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults. (2021) (28)
- Association between Heat Exposure and Hospitalization for Diabetes in Brazil during 2000–2015: A Nationwide Case-Crossover Study (2019) (27)
- Time series modelling to forecast prehospital EMS demand for diabetic emergencies (2017) (26)
- Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease. (2014) (25)
- Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes. (2019) (25)
- Predicting 6‐month mortality risk of patients commencing dialysis treatment for end‐stage kidney disease (2017) (25)
- Predictors of first‐year nonadherence and discontinuation of statins among older adults: a retrospective cohort study (2018) (25)
- Effectiveness and implementation of an obesity prevention intervention: the HeLP-her Rural cluster randomised controlled trial (2014) (24)
- Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL. (2017) (23)
- Treatment of Dyslipidemia and Cardiovascular Outcomes: The Journey So Far—Is This the End for Statins? (2014) (23)
- Utilisation of emergency medical services for severe hypoglycaemia: An unrecognised health care burden. (2016) (23)
- A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data (2018) (23)
- Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment? (2020) (22)
- Young‐onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications (2020) (22)
- The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE study. (2017) (22)
- Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA) (2018) (22)
- Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study (2017) (21)
- Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial (2018) (21)
- Atherosclerosis and folic acid supplementation trial in chronic renal failure: Baseline results (2004) (21)
- Measures of Population Ageing in Australia from 1950 to 2050 (2018) (20)
- Obesity, polycystic ovary syndrome and breastfeeding: an observational study (2016) (20)
- Prediction of 10‐year vascular risk in patients with diabetes: the AD‐ON risk score (2016) (20)
- Emergency treatment of hypoglycaemia: a guideline and evidence review (2017) (20)
- Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis (2020) (20)
- Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes Audit (2018) (19)
- Breathing life into Australian diabetes clinical guidelines (2020) (19)
- Younger people with Type 2 diabetes have poorer self‐care practices compared with older people: results from the Australian National Diabetes Audit (2018) (19)
- Statins in the elderly: an answered question? (2014) (19)
- Interventions for lowering plasma homocysteine levels in kidney transplant recipients. (2015) (18)
- Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness (2020) (18)
- Evidence-based Guidelines for Perioperative Management of Diabetes in Cardiac and Vascular Surgery (2010) (18)
- Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: a mixed-methods exploration. (2016) (18)
- Primary and tertiary health professionals’ views on the health-care of patients with co-morbid diabetes and chronic kidney disease – a qualitative study (2016) (18)
- Switching, Discontinuation, and Reinitiation of Statins Among Older Adults. (2018) (18)
- Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. (2022) (17)
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. (2020) (17)
- Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. (2015) (17)
- Effect of diabetes and pre-hospital blood glucose level on survival and recovery after out-of-hospital cardiac arrest. (2016) (16)
- Intensification of medication and glycaemic control among patients with type 2 diabetes – the ADVANCE trial (2014) (16)
- Type 2 Diabetes Patients' Perspectives, Experiences, and Barriers Toward Diabetes-Related Self-Care: A Qualitative Study From Pakistan (2020) (16)
- The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
- Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes (2019) (14)
- Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome. (2019) (14)
- SGLT2 Inhibitors in Diabetic Kidney Disease. (2021) (13)
- The genomic potential of the Aspirin in Reducing Events in the Elderly and Statins in Reducing Events in the Elderly studies (2017) (13)
- Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function (2002) (13)
- The association of smoking status with glycemic control, metabolic profile and diabetic complications- Results of the Australian National Diabetes Audit (ANDA). (2020) (13)
- Effectiveness of management models for facilitating self-management and patient outcomes in adults with diabetes and chronic kidney disease (2015) (13)
- The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study (2019) (12)
- The impact of glycaemic control on outcomes in patients with end‐stage renal disease and type 2 diabetes (Review Article) (2008) (12)
- Randomized, placebo‐controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients (2003) (12)
- Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia (2018) (11)
- Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes (2018) (11)
- Does Glycemic Control Offer Similar Benefits Among PatientsWith Diabetes in Different Regions of theWorld? Results from the ADVANCE trial (2011) (11)
- Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention (2010) (11)
- Interventions for lowering plasma homocysteine levels in dialysis patients. (2016) (11)
- Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
- Cost-effectiveness analysis of a hybrid closed-loop system versus multiple daily injections and capillary glucose testing for adults with type 1 diabetes. (2020) (11)
- Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function. (2002) (11)
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. (2021) (10)
- Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial (2020) (10)
- A lifestyle intervention programme for the prevention of Type 2 diabetes mellitus among South Asian women with gestational diabetes mellitus [LIVING study]: protocol for a randomized trial (2018) (10)
- Reinitiation of Statin Therapy After Discontinuation: A Meta‐analysis (2018) (10)
- Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis (2020) (10)
- ADVANCE in context: The benefits, risks and feasibility of providing intensive glycaemic control based on gliclazide modified release (2020) (10)
- Changes in plasma lipids predict pravastatin efficacy in secondary prevention. (2019) (9)
- Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study (2020) (9)
- Models of care for co‐morbid diabetes and chronic kidney disease (2018) (9)
- LDL‐Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk (2018) (8)
- Individual, social and environmental factors and their association with weight in rural‐dwelling women (2017) (8)
- Outcomes of people with severe hypoglycaemia requiring prehospital emergency medical services management: a prospective study (2019) (8)
- Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. (2010) (8)
- Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial (2018) (8)
- Intensive glucose‐lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial (2019) (8)
- Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data (2020) (8)
- The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? (2013) (8)
- Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease. (2019) (7)
- EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study (2020) (7)
- Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusNovelty and Significance (2015) (7)
- Development, Relative Validity and Reproducibility of the Aus-SDS (Australian Short Dietary Screener) in Adults Aged 70 Years and above (2020) (7)
- Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients with Type 2 Diabetes. (2020) (7)
- PREDICTIVE VALUE OF PULSE WAVE VELOCITY FOR CARDIOVASCULAR EVENTS IN 15220 SUBJECTS: AN INDIVIDUAL PARTICIPANT META-ANALYSIS ON BEHALF OF THE PWV COLLABORATIVE GROUP: HT.3.03 (2010) (7)
- Statins: Neurobiological underpinnings and mechanisms in mood disorders (2021) (7)
- Prevalence and risk factors of prediabetes after renal transplantation : a single-centre cohort study in 200 consecutive patients (7)
- The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes Mellitus (2014) (7)
- Predictors of statin use among older adults: A nationwide cross-sectional study. (2019) (7)
- Abstract #259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin (2019) (6)
- Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study (2017) (6)
- Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome (2007) (6)
- Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression Approach (2019) (6)
- Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review (2017) (6)
- A need-based approach to self-management education for adults with co-morbid diabetes and chronic kidney disease (2019) (6)
- Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303 (2015) (5)
- Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes (2022) (5)
- Glycaemia and utilisation of technology across the lifespan of adults with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA). (2020) (5)
- How much is enough? An investigation of the relationship between haemodialysis adequacy and quality of life of elderly patients (2016) (5)
- Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarking (2018) (5)
- Glucose lowering therapies for chronic kidney disease and kidney transplantation (2012) (5)
- Mental Health Outcomes in Australian Healthcare and Aged-Care Workers during the Second Year of the COVID-19 Pandemic (2022) (5)
- Antiplatelet agents for chronic kidney disease (2013) (5)
- Understanding implementability in clinical trials: a pragmatic review and concept map (2021) (5)
- Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes (2016) (5)
- Impact of COVID-19 on Diabetes Health Care and Service Provision in Australian Diabetes Centers (2021) (5)
- Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review (2018) (5)
- Trends in glycaemic control and drug use in males and females with type 2 diabetes: Results of the Australian National Diabetes Audit from 2013 to 2019 (2021) (5)
- Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program (2021) (4)
- Diabetes: Glycemic control and outcomes in people with diabetes and CKD (2012) (4)
- The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges. (2013) (4)
- Management of type 2 diabetes in young adults aged 18–30 years: ADS/ADEA/APEG consensus statement (2022) (4)
- Patterns of Medication Dispensation for Multiple Comorbidities among Older Adults in Australia (2018) (4)
- Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis. (2021) (4)
- Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial (2011) (4)
- Trends in the Dispensing and Costs of Glucose-Lowering Medications Among Older Australians: Findings from National Claims Data (2020) (3)
- Review: An Australian model of care for co-morbid diabetes and chronic kidney disease. (2018) (3)
- Prognostic value of carotid-femoral pulse wave velocity for cardiovascular events: An IPD meta-analysis of prospective observational data from 14 studies including 16,358 subjects (2011) (3)
- How to read a report of a randomized controlled trial (2010) (3)
- Intensive glucose-lowering therapy in people with type 2 diabetes: what do we learn from a new meta-analysis of randomised controlled trials? (2011) (3)
- Intensive glucose control is renoprotective in type 2 diabetes (2010) (3)
- Post-Hoc Subgroup Analysis of a Randomized Controlled Trial Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease: A (2010) (3)
- Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies (2016) (3)
- Real-time continuous glucose monitoring improves glycaemic variability and neonatal outcomes in pregnant women with type 1 diabetes (2018) (2)
- The Cost of Control: Cost-Effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth. (2022) (2)
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective (2020) (2)
- Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease (2018) (2)
- Geographical variation of diabetic emergencies attended by prehospital Emergency Medical Services is associated with measures of ethnicity and socioeconomic status (2018) (2)
- Barriers to healthy lifestyle behaviours and adherence to physical activity and dietary guidelines by older Australians: A descriptive analysis (2021) (2)
- Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. (2022) (2)
- Comparing two methods for delivering clinical trial informed consent information to older adults: singular versus stepped approach (2018) (2)
- Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction (2022) (2)
- Missing data and multiple imputation when predicting mortality in incident dialysis patients. (2011) (2)
- Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis (2021) (2)
- CANCER AND CHRONIC KIDNEY DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF 33,618 PARTICIPANTS (2014) (2)
- Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation (2022) (2)
- THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
- Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults (2021) (2)
- Antiplatelet agents for chronic kidney disease (Review) (2013) (2)
- Screening for glycaemic abnormalities in PCOS: an ongoing controversy. (2013) (2)
- Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
- Obesity and the microvasculature (2013) (2)
- Younger Patients with Type 2 Diabetes Have Poorer Self-Care Practices Compared with Older Patients—Results from the Australian National Diabetes Audit (2018) (1)
- Plasma lipidomic profiles in two large independent cohorts improve upon conventional risk factors to predict cardiovascular events. (2016) (1)
- Mental health and wellbeing of health and aged care workers in Australia, May 2021 – June 2022: a longitudinal cohort study (2023) (1)
- Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertain (2017) (1)
- Cardiovascular disease and malignant melanoma (2022) (1)
- The Effects of a Lifestyle Intervention to Prevent Deterioration in Glycaemic Status Among South Asian Women with Recent Gestational Diabetes Mellitus: A Randomised Control Trial (2021) (1)
- Reducing renal failure: how low do glucose levels need to go? (2012) (1)
- Pre-operative Kidney Function as a Predictor of Adverse Outcomes after Surgery: A Systematic Review and Meta-analysis (2011) (1)
- Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial (2020) (1)
- Burden of Cardiovascular Risk Factors and Disease in Type 1 Diabetes—Results of the Australian National Diabetes Audit (ANDA) (2018) (1)
- Aspirin therapy in diabetes: evidence and current recommendations (2020) (1)
- The atherosclerosis and folic acid supplementation trial in patients with chronic renal failure (ASFAST): baseline results (2003) (1)
- Chronic kidney disease, cardiovascular events and the effect of diabetes: post hoc analyses from ASFAST (2008) (1)
- Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes (2019) (1)
- The Effects of Statins on Physical Activity or Physical Fitness Among Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2019) (1)
- THE ATHEROSCLEROSIS AND FOLIC ACID SUPPLEMENTATION TRIAL IN CRF (ASFAST): RATIONALE, DESIGN AND BASELINE RESULTS (2002) (1)
- Antioxidants for chronic kidney disease (Review) (2014) (1)
- The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes (2013) (1)
- Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update (2023) (1)
- EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study (Preprint) (2019) (1)
- Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/H (2015) (1)
- Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population (2010) (1)
- OPINION Statins in the elderly: an answered question? (2014) (1)
- Erratum to: Intensive glucose control and risk of cancer in patients with type 2 diabetes (2013) (1)
- Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial (2012) (1)
- Older participant perspectives on permanent study drug discontinuation in an ongoing primary prevention trial of statins (2021) (1)
- Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study (2009) (1)
- Diabetes and CVD risk in women. Optimising outcomes (2015) (1)
- Protective lipid-lowering variants in healthy older individuals without coronary heart disease (2021) (1)
- Intensive glucose control in patients with type 2 diabetes is associated with a reduction in albuminuria and may be associated with reduced end-stage renal disease (2012) (1)
- Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis (2020) (1)
- Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019. (2022) (1)
- Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National Diabetes Audit (ANDA) 2016 (2018) (1)
- Making the most of audit and feedback to improve diabetes care: a qualitative study of the perspectives of Australian Diabetes Centres (2022) (1)
- Chair of session: Dementia, Depression and Diabetes (2010) (0)
- Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
- A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care. (2021) (0)
- Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial (2012) (0)
- High Incidence of Hypoglycemia from an Audit of Glycemic Control and Management in Patients with Diabetes in a Cardiac Unit (2013) (0)
- Cardiovascular complications - 2 (2009) (0)
- Arterial stiffness and IMT are increased in patients with chronic renal failure (1999) (0)
- 170-LB: Efficacy and Safety of Technology in Type 1 Diabetes: A Systematic Review and Network Meta-analysis (2019) (0)
- The authors reply. (2021) (0)
- IDF2022-1146 Longitudinal relationship between glycemic status and disability-free survival in a community-dwelling older cohort (2023) (0)
- 356Impact of site-specific and patient-specific factors in explaining HbA1c variation in Australian diabetes centres (2021) (0)
- Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
- 251-OR: Relationship of Short-Term HbA1c Change with Vascular Events, Severe Hypoglycaemia, and Mortality (2019) (0)
- Critical appraisal of randomized controlled trials [Invited speaker] (2010) (0)
- Caution in clinical interpretation of population level administrative data (2017) (0)
- Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. (2020) (0)
- Type 2 Diabetes Mellitus Resting Heart Rate and the Risk of Microvascular Complications in Patients With Copyright (2012) (0)
- Understanding the effects of interventions; assessing cardiovascular outcomes [Invited] (2013) (0)
- Management of chronic kidney disease in Australian general practice (the AusHEART Study) (2010) (0)
- SUN-128 A CO-DESIGNED INTEGRATED DIABETES AND KIDNEY DISEASE MODEL OF CARE IMPROVES DIABETES SELF-CARE AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE (2020) (0)
- Reduced vascular access thrombosis with folic acid: the AFAST randomized placebo controlled trial (2008) (0)
- MON-278 THE IMPACT OF AN INTEGRATED DIABETES AND KIDNEY SERVICE ON PATIENTS, PRIMARY AND SPECIALIST HEALTH PROFESSIONALS: A QUALITATIVE STUDY (2019) (0)
- The world’s largest study of Type 2 diabetes treatments (2008) (0)
- Protocol Patterns and Predictors of Adherence to Statin Therapy Among Older Patients : Protocol for a Systematic Review (2017) (0)
- RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: 7E.03 (2011) (0)
- Abstract 12172: HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes (2012) (0)
- Benefits of Intensified Reductions in Blood Glucose and in Blood Pressure for Patients with Type 2 Diabetes. (2022) (0)
- The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus (2013) (0)
- ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter] (2012) (0)
- Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes (2023) (0)
- SUN-266 HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE ATTENDING A CO-DESIGNED INTEGRATED MODEL OF CARE: A LONGITUDINAL STUDY (2019) (0)
- Breastfeeding in women with Polycystic ovary syndrome: Data from the Australian longitudinal women's health study (2013) (0)
- The authors reply:. (2013) (0)
- [Keynote speaker] Strategies to prevent Contrast-induced nephropathy (2010) (0)
- OPTIMAL HYPERTENSION MANAGEMENT WITH PRETERAX: S3.1 (2010) (0)
- Navigating the new diabetes drugs: cardiovascular benefits and when to use (2019) (0)
- in people with type-2 diabetes : a prospective cohort study from ADVANCE Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk (2011) (0)
- 68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2012) (0)
- Does Glucose lowering prevent cardiovascular disease? [Invited speaker] (2010) (0)
- Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study (2022) (0)
- Diabetes: Insights from the extended follow-up of the ACCORD trial (2011) (0)
- Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors (2022) (0)
- Protective lipid-lowering genetic variants in healthy older individuals without coronary heart disease (2021) (0)
- P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM (2020) (0)
- 733 WITHDRAWN:Â Health Economic Evaluation of Screening and Treating Children With Familial Hypercholesterolemia Early in Life: Many Happy Returns on Investment? (2020) (0)
- Are SGLT2 Inhibitors Safe and Effective in Advanced Diabetic Kidney Disease? (2020) (0)
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis (2022) (0)
- Mapping care provision for type 1 diabetes throughout Australia: a protocol for a mixed-method study (2022) (0)
- HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes (2012) (0)
- Changes in Albuminuria and the Risk ofMajor (2017) (0)
- 743 WITHDRAWN:Â Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness. (2020) (0)
- Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial) (2023) (0)
- Diabetes and cardiac health: challenges to risk assessment and prevention strategies (2017) (0)
- Association Between Dietary Intake and Lipid-lowering Therapy: Prospective Analysis Using a Quantile Regression Approach (OR22-03-19). (2019) (0)
- Debate: Older is Wiser in the Art of Medicine (2010) (0)
- Association of HDL Cholesterol with Cancer Incidence in Type 2 Diabetes: A Case of Reverse Causality? (2012) (0)
- Population Genomic Screening of Young Adults for Familial Hypercholesterolaemia: A Cost-Effectiveness Analysis (2022) (0)
- [Abstract] Comparison of various anthropometric indices as predictors of cardiovascular disease in patients with type 2 diabetes (2009) (0)
- Reply to: Statins for Primary Prevention in Older Adults (2019) (0)
- Central obesity markers, but not BMI, are associated with cardiovascular risk in type 2 diabetic patients: results from the ADVANCE study (2009) (0)
- Microvascular outcomes in type 2 diabetes - Authors' reply. (2017) (0)
- Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials (2021) (0)
- BP management in Diabetes: Have we reached the limit? [Invited speaker] (2010) (0)
- The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
- Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis. (2022) (0)
- Ultrasound Imaging for R gional Anesthesia in Infants , Children , and Adolescents (2013) (0)
- The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trials: 'good to know' but not the whole story. (2019) (0)
- Author response for "SGLT2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes" (2020) (0)
- 176 The Cost-Effectiveness of Dapagliflozin for Chronic Heart Failure in Australia (2020) (0)
- ANDA-Evaluating Facilitated Feedback Enhancement - a Cluster randomised Trial (ANDA-EFFECT): protocol for a cluster randomised trial of audit feedback augmented with education and support, compared to feedback alone, on acceptability, utility and health outcomes in diabetes centres in Australia (2022) (0)
- Abstract P209: Effects of Blood Pressure Lowering on Vascular Outcomes in Different Cardiovascular Risk Groups Among Patients With Type 2 Diabetes: New Results From Advance (2012) (0)
- Abstract P031: Weight Changes and Their Predictors Among 11,140 Patients With Type 2 Diabetes in The Advance Trial (2012) (0)
- Severe hypoglycemia was associated with increased risk for adverse clinical outcomes in type 2 diabetes (2011) (0)
- Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial (2023) (0)
- SAT-294 RANDOMISED EFFECTS OF INTENSIVE GLUCOSE-LOWERING THERAPY ON THE RISK OF MAJOR CLINICAL OUTCOMES IN TYPE 2 DIABETES ACCORDING TO eGFR AND UACR LEVELS (2019) (0)
- Abstract 13812: The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
- Abstract 18688: Plasma Lipid Profiling to Predict Cardiovascular Events in Type 2 Diabetes (2014) (0)
- Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37:1353–1359 (2015) (0)
- Effects of renal transplantation on arterial function (2003) (0)
- HDL Cholesterol is a Risk Factor for Diabetic Nephropathy But Not Retinopathy—Results From the ADVANCE Study (2011) (0)
- Arterial Function ARTERIAL STIFFNESS AND CARDIOVASCULAR OUTCOME (2007) (0)
- Chronic Kidney Disease and Cardiovascular risk (Co Chair of session entitled “Bones, Hearts and Kidneys”) [Invited speaker] (2010) (0)
- Geographical variation of diabetic emergencies attended by prehospital Emergency Medical Services is associated with measures of ethnicity and socioeconomic status (2018) (0)
- Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarking (2018) (0)
- SUN-129 ACTIVATION LEVELS AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE ATTENDING A CO-DESIGNED INTEGRATED MODEL OF CARE: A LONGITUDINAL STUDY (2020) (0)
This paper list is powered by the following services:
Other Resources About Sophia Zoungas
What Schools Are Affiliated With Sophia Zoungas?
Sophia Zoungas is affiliated with the following schools:
